Seattle Genetics | Zysk Z Działalności Operacyjnej



Operating Profit Zmiana Data
AbbVie USD 3.73B 5.22B 2025-03
Acadia Pharmaceuticals USD 19.29M 134.21M 2025-03
Agios Pharmaceuticals USD -106629000 18.41M 2025-03
Amgen USD 1.29B 1.02B 2025-03
Astellas Pharma JPY 63.52B 179.71B 2025-03
Bayer EUR 2.32B 1.21B 2025-03
Biogen USD 311.2M 130.2M 2025-03
BioMarin Pharmaceutical USD 223.89M 62.49M 2025-03
Bristol-Myers Squibb USD 3.41B 2.62B 2025-03
Celldex Therapeutics USD -62739000 6.71M 2025-03
Daiichi Sankyo JPY 83.61B 22.2B 2025-03
Eisai JPY -1024000000 28.59B 2025-03
Eli Lilly USD 5.41B 259.6M 2025-03
Exelixis USD 186.86M 23.65M 2025-04
Genmab DKK 188M 2B 2025-03
Gilead Sciences USD 2.24B 215M 2025-03
GlaxoSmithKline GBP 2.22B 1.52B 2025-03
Glaxosmithkline GBP 702M 513M 2024-12
Incyte USD 205.17M 96.34M 2025-03
Insmed USD -248140000 17.73M 2025-03
MacroGenics USD -16587000 70.78M 2024-12
Merck USD 5.87B 1.57B 2025-03
Moderna USD -1050000000 196M 2025-03
Novartis USD 2.28B 1.34B 2024-12
Pfizer USD 3.67B 4.08B 2025-03
Regeneron Pharmaceuticals USD 591.7M 398.5M 2025-03
Sanofi EUR 2.28B 1.42B 2025-03
Sarepta Therapeutics USD -300386000 462.07M 2025-03
Takeda JPY -74932000000 141.87B 2025-03
Teva Pharmaceutical Industries USD 519M 64M 2025-03
Vertex Pharmaceuticals USD 1.03B 90.3M 2024-12
Xencor USD -43183000 47.23M 2025-03



Seattle Genetics Zysk Z Działalności Operacyjnej - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Jul 2025.